Abstract
This paper focuses on the importance of data collected not only from controlled clinical trials, but also from naturalistic treatment experience. In particular we examine the use of divalproex sodium either as monotherapy or as part of combined therapy on an in-patient ward for adolescents aged 13-18 years. All admissions in which divalproex sodium use was attempted (n=36) were analysed over a 1-year period. The most common use was in patients with a mixed-presentation bipolar disorder (n=16), followed by patients with major depression (n=7), mania (n=4) or psychoses not otherwise specified (n=4). Divalproex sodium use was evaluated in the control of mania, psychosis, agitation, mood swings, aggression and/or anxiety. Overall, the use of divalproex sodium was associated with a marked improvement along all psychopathological variables in the vast majority of patients. Few side-effects or medical complications were noted. We believe that divalproex sodium is a potentially useful drug in adolescent patients with varying forms of psychopathology.
References
Feb 1, 1978·Archives of General Psychiatry·J Youngerman, I A Canino
Jan 1, 1992·The American Journal of Psychiatry·T W FreemanA C Swann
Jan 11, 1991·Archives of General Psychiatry·H G PopeJ I Hudson
Nov 1, 1988·Journal of Affective Disorders·M StroberR Freeman
May 1, 1987·Journal of the American Academy of Child and Adolescent Psychiatry·G R DeLong, A L Aldershof
May 1, 1985·Pharmacotherapy·E M Rimmer, A Richens
Jul 1, 1980·Comprehensive Psychiatry·C L Bowden, F Sarabia
Apr 1, 1995·Journal of Clinical Psychopharmacology·G PapatheodorouJ P Szalai
Jan 1, 1993·Psychopharmacology·E VasarP T Männistö
Mar 1, 1994·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·J Wilcox
Mar 23, 1994·JAMA : the Journal of the American Medical Association·C L BowdenJ G Small
Jan 1, 1996·European Psychiatry : the Journal of the Association of European Psychiatrists·I MaremmaniJ Deltito
Citations
Dec 1, 2006·European Child & Adolescent Psychiatry·Angèle ConsoliDavid Cohen
Jun 16, 2007·Child Psychiatry and Human Development·Hans SteinerKiki Chang
Dec 21, 2000·Current Psychiatry Reports·G A Carlson, S E Meyer
Oct 27, 2006·Development and Psychopathology·Melissa P DelBello, Robert A Kowatch
Dec 13, 2006·Harvard Review of Psychiatry·Melissa Lopez-Larson, Jean A Frazier
Jul 29, 2009·Harvard Review of Psychiatry·Daniel V Vigo, Ross J Baldessarini
Feb 24, 2004·Journal of Child and Adolescent Psychopharmacology·Charles A HenryS Nassir Ghaemi
Jan 15, 2005·Journal of Child and Adolescent Psychopharmacology·Michael S Barnett
Aug 10, 1999·Current Opinion in Pediatrics·A S Robb
Oct 14, 2005·Paediatric Drugs·Arman Danielyan, Robert A Kowatch
Jul 31, 2009·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·U WinterfeldO Bourdon
Mar 1, 2002·Journal of Affective Disorders·J DeltitoP Corless C Morse
Sep 28, 2010·Bipolar Disorders·Mani N PavuluriJohn A Sweeney
Jun 7, 2014·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Covadonga M Díaz-CanejaDolores Moreno
Apr 8, 2003·CNS Spectrums·Robert A Kowatch, Melissa P DelBello
Apr 6, 2004·The Psychiatric Clinics of North America·Elizabeth B WellerRonald A Weller
Jan 24, 2012·Journal of the American Academy of Child and Adolescent Psychiatry·Mani N PavuluriJohn A Sweeney
Nov 6, 2004·Journal of Child Neurology·James W Wheless, Blaise F D Bourgeois
Aug 12, 2009·Nature Reviews. Neurology·Eric Taylor
Jun 7, 2005·Expert Opinion on Pharmacotherapy·Gabriele Masi
Jan 26, 2000·Journal of Clinical Psychopharmacology·L L DavisF Petty
Jan 22, 2003·The Cochrane Database of Systematic Reviews·K MacritchieG Goodwin
Jun 5, 2003·Bipolar Disorders·Charles L Bowden
Aug 5, 2003·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Lindley Bassarath